using model based meta analysis to inform drug development for auto immune diseases
Published 6 years ago • 651 plays • Length 33:21Download video MP4
Download video MP3
Similar videos
-
45:33
using model-based meta-analysis to improve decision-making in drug development
-
1:00:21
optimize drug development with public data and predictive models – model-based meta-analysis (mbma)
-
57:46
model-based meta-analysis for comparative efficacy and safety of therapeutics for covid-19
-
16:21
using autoimmune disease models in pre-clinical drug discovery
-
4:16
certara's virtual twin: optimizing neurodegenerative disease development with predictive modeling
-
44:57
using modeling and simulation to optimize dosing of an anti-infective for children
-
15:51
model informed drug development approaches for immunogenicity assessments workshop
-
11:17
modeling and simulation to support pediatric drug development
-
22:41
model-based meta-analysis of anti-tuberculosis regimen efficacy in relapsing mouse model studies
-
10:17
certara - improving investment in drug development through biosimulation
-
33:59
the role of midd in drug development for covid-19
-
45:02
building an mbma framework to support developing new neuropathic pain drugs
-
8:03
what are autoimmune diseases and how do they develop?
-
35:08
fda modernization act - what does it mean for pharmaceutical scientists?
-
6:24
predicting and taming immunogenicity: what is an integrated summary of immunogenicity (isi)?
-
1:03:33
pharmacometrics symposium: applied meta-analysis in drug development
-
55:53
mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology
-
58:45
best practices in clinical pharmacology gap analysis